LOS ANGELES -- For surgeons already split on their preference of inhaled pulmonary vasodilator to prevent postoperative right ...
Several years ago, a little-known drug named Ozempic—previously used only to treat diabetes—emerged as a promising new drug ...
If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...
Researchers have identified new lung function and blood test cutoffs to improve timely chronic hypercapnia management in ...
Certain Medicare plans typically cover at least part of the cost of inhalers for COPD. There are also several ways to further save on costs.
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...
Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.
The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback